A double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair | Signal Transduction and Targeted Therapy
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Characterization of Screen Failures Among Patients Evaluated for Transcatheter Tricuspid Valve Repair (TriSelect-Study) | JACC: Cardiovascular Interventions
Sensors | Free Full-Text | Feasibility and First Results of Heart Failure Monitoring Using the Wearable Cardioverter–Defibrillator in Newly Diagnosed Heart Failure with Reduced Ejection Fraction
Cardiomyocyte-specific disruption of soluble epoxide hydrolase limits inflammation to preserve cardiac function | American Journal of Physiology- Heart and Circulatory Physiology
Will introduction of ARNI reduce the need of device therapy in heart failure with reduced ejection fraction? | The Egyptian Heart Journal | Full Text
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Cancers | Free Full-Text | Harnessing RKIP to Combat Heart Disease and Cancer
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Ultromics joins FNIH partnership to transform heart failure detection - Ultromics
Use of evidence‐based therapy in heart failure with reduced ejection fraction across age strata - Stolfo - 2022 - European Journal of Heart Failure - Wiley Online Library
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart Association | Circulation: Genomic and Precision Medicine
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
APP Webinar (Full Length): BAT - A Novel Approach to Class II/III Heart Failure Management - YouTube
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Frontiers | Device-based therapy for decompensated heart failure: An updated review of devices in development based on the DRI2P2S classification
Heart Failure Strategically Focused Research Network: Summary of Results and Future Directions | Journal of the American Heart Association
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
The role of the genome regulatory network in heart failure | Nature Cardiovascular Research
Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction | Circulation: Arrhythmia and Electrophysiology
